2) Difference plot for HRM analysis of IDH1 mutations normalised to wt allele, discrimination of different mutations was difficult because of similar graphs. 3) Difference plot for HRM analysis of IDH1 mutations normalised to the R132S C>A allele, determination of different mutations was easier because of clearly separated graphs. Figure 8 Sensitivity analysis of different IDH1 mutations. 1) Difference plot for HRM analysis of serial dilutions of IDH1 G105 C>T: Undiluted

https://www.selleckchem.com/products/4egi-1.html mutation ratio was 51.9% (estimated by sequencing). Correct estimation was possible up to a mutation ratio of 7.8%; lower mutation ratios were identified false-negative. Normalisation was performed to the R132S C>A allele. 2) Difference plot for HRM analysis of serial

dilutions of IDH1 R132C C>T: Undiluted mutation ratio was 44.6% (estimated by sequencing). Correct estimation was possible up to a mutation click here ratio of 6.69%; lower mutation ratios were identified false-negative. Ilomastat order Normalisation was performed to the R132S C>A allele. 3) Difference plot for HRM analysis of serial dilutions of IDH1 R132S C>A: Undiluted mutation ratio was 40.4% (estimated by sequencing). Correct estimation was possible up to a mutation ratio of 6%, lower mutation ratios were identified false-negative. Normalisation was performed to the G105 C>T allele. Combination of different methods is essential to identify DNMT3A and IDH1/2 mutations in routine laboratory analyses Both the assays designed in this study for the detection of DNMT3A R882H and IDH2 R140Q mutations were completely compliant with Sanger sequencing and had a high specificity. No false-positive results were determined with HRM analysis. Two (0.9%)

samples showed variations for DNMT3A but were subsequently determined as wt by endonuclease restriction and sequencing. IDH1 analysis with HRM showed that 6 (2.6%) samples had inaccuracies in melting profiles and hence were determined false negative with this method. Sequencing showed the presence of a R132C C>T mutation in this samples. IDH2 analysis showed no discrepancies with Sanger sequencing. Compared to Sanger sequencing, HRM analysis represents a timesaving, cost-efficient and more sensitive method to screen mutations in patients with AML at diagnosis. However, an efficient application presumes the presence of specific mutations and wt control selleck chemicals llc samples. Because of the lack of cell lines with DNMT3A, IDH2 and IDH1 mutations, controls have to be established by sequencing different patient samples. Therefore, an effective application of HRM depends on the identification of high amounts of good-quality control samples, availability of a sequencer and HRM competent real-time PCR cycler. In addition, some results obtained with HRM analysis are difficult to interpret because of the variations in the melting curve of 1 mutation and can lead to uncertain conclusions or false-negative results [31].